This systematic review and meta-analysis clarifies the major and minor risk factors associated with developing early-onset food allergy to inform optimal prevention clinical practice, policy, and ...

Market OverviewThe global allergy diagnostics market is expected to witness strong growth at a compound annual growth rate of ...

A new study led by investigators at National Jewish Health and published in Annals of Allergy, Asthma & Immunology shows that ...

Researchers found that dupilumab improved skin barrier integrity and reduced inflammation in children with atopic dermatitis.

Presentations among children with multiple food allergies vary by allergen combination, indicating distinct phenotypes, ...

A long-term analysis offers reassurance to users of the topical treatment recently approved for children down to age 2.

True IgE-mediated local anesthetic hypersensitivity is <1% of reported reactions, so risk reduction should prioritize preservative-free amide selection, minimal effective dosing, and strict avoidance ...

Children who develop eczema or other skin and respiratory allergies early in life face a higher risk of developing a food allergy, according to a recent study published in JAMA Pediatrics.

USA: A subgroup analysis published in The Journal of Allergy and Clinical Immunology reports that roflumilast cream may provide sustained improvement in patients with atopic dermatitis, including ...

For children with atopic dermatitis (AD), dupilumab treatment restores skin barrier function, according to a study published ...

Extreme weather and warming temperatures fueled by climate change make pollen seasons longer, more intense, worsening seasonal pollen allergies for millions 2026 Allergy Capitals Report AAFA releases ...

Lebrikizumab delivered significant skin clearance and improved disease severity in children with moderate-to-severe atopic dermatitisADorable-1 met co-primary efficacy endpoints, with 63% of ...